Asia-Pacific Precision Medicine Market to reach $7,746 million by 2031 from $3,516 million in 2022, at a CAGR of 11.9% during the forecast period
Key Companies Covered in the Asia-Pacific Precision Medicine Market Research are Almac Group, Ltd, Asuragen, Inc., Cepheid Inc, Cetics Healthcare Technologies GmbH, Ge Healthcare, Glaxosmithkline Plc, Into ics A/S., Biocrates Life Sciences Ag, and Pfizer Inc. and other key market players . The global Asia-Pacific Precision Medicine Market size is projected to reach $7,746 million by 2031 from $3,516 million in 2022, at a CAGR of 11.9% during the forecast period . Kenneth Research has evaluated the current market opportunities in Asia-Pacific Precision Medicine Market in the healthcare industry for the forecast period 2022-2031, which also includes the ongoing industry trends and innovations that will help industry players to attain their business targets. Apart from that, the inclusive data on market size, market share and forecast, growth opportunities and challenges for the market players, along with the worldwide analysis ...